10 hours ago
2
JHVEPhoto
Teva Pharmaceuticals (NYSE:TEVA) said that the U.S. FDA has granted fast track designation to its experimental therapy TEV-56286 (emrusolmin) for treating Multiple System Atrophy.
Emrusolmin, developed in partnership with German biotech company MODAG GmbH, is currently being tested in a phase
English (US) ·